Rituximab biosimilar, premium grade, Unconjugated, Human
Biozol Catalog Number:
ABS-CD0-M36A2-500UG
Supplier Catalog Number:
CD0-M36A2-500ug
Alternative Catalog Number:
ABS-CD0-M36A2-500UG
Manufacturer:
AcroBiosystems
Host:
Human
Category:
Antikörper
Species Reactivity:
Mouse
Conjugation:
Unconjugated
Rituximab biosimilar, premium grade (CD0M36A2) is a chimeric monoclonal antibody recombinantly produced from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. - Antikörper
Tag:
Human IgG1 | Human Kappa
Buffer:
25 mM Sodium citrate, 150 mM NaCl, pH6.5
Purity:
0.95
Form:
Liquid
Target:
CD20
Immobilized Biotinylated Human CD20 Full Length, His,Avitag (Cat. No. CD0-H82E5) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Rituximab biosimilar, premium grade (Cat. No. CD0-M36A2) with a linear range of 0.031-1 µg/mL (QC tested).
Immobilized Human CD20 Full Length Protein-VLP (Cat. No. CDP-H52P6) at 5 µg/mL (100 µL/well) can bind Rituximab biosimilar, premium grade (Cat. No. CD0-M36A2) with a linear range of 0.016-1 µg/mL (Routinely tested).
Rituximab biosimilar, premium grade on SDS-PAGE under reducing (R) and under non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.
* VAT and and shipping costs not included. Errors and price changes excepted
